Narayan K, Fisher R J, Bernshaw D
Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Int J Gynecol Cancer. 2008 May-Jun;18(3):525-33. doi: 10.1111/j.1525-1438.2007.01050.x.
Earlier we had shown that tumor volume and corpus invasion were important prognostic factors in cervical cancer and that corpus invasion was associated with nodal metastases. In view of these findings, we wanted to examine the factors associated with the patterns of relapse in cervical cancer patients who were staged by magnetic resonance imaging (MRI) and treated with curative intent. This was a retrospective study of locoregionally advanced cervical cancer patients treated with curative intent. All patients had examination under anesthesia and pretreatment MRI. Potential prognostics examined were FIGO stage, clinical diameter, histology, corpus invasion, tumor volume, and age. Outcome measures examined were times to failure, local failure, nodal failure, and distant failure. There were 249 eligible patients. The median age of the patients was 58 years, 85% had squamous histology, and 63% of tumors exhibited corpus invasion. Median tumor volume was 33.5 mL (range 1-628). The mean follow-up was 4.5 years. Eighty-five patients had relapsed and 89 died (70 following failure and 19 otherwise). At 5 years, for all patients, the failure-free rate was 62%, the local failure-free rate 88%, the nodal failure-free rate 69%, and the distant failure-free rate 74%. Corpus invasion, tumor volume, and age were all highly significantly and independently related to risk of failure at local, nodal, and distant (except tumor volume) sites. In the presence of these factors, clinical tumor diameter and FIGO stage were not significantly related to risk of any type of failure.
我们之前已经表明,肿瘤体积和宫体侵犯是宫颈癌重要的预后因素,且宫体侵犯与淋巴结转移相关。鉴于这些发现,我们想要研究在经磁共振成像(MRI)分期并接受根治性治疗的宫颈癌患者中,与复发模式相关的因素。这是一项针对接受根治性治疗的局部晚期宫颈癌患者的回顾性研究。所有患者均接受了麻醉下检查和治疗前MRI检查。所检测的潜在预后因素包括国际妇产科联盟(FIGO)分期、临床直径、组织学类型、宫体侵犯、肿瘤体积和年龄。所检测的结局指标包括至失败时间、局部失败、淋巴结失败和远处失败。共有249例符合条件的患者。患者的中位年龄为58岁,85%为鳞状组织学类型,63%的肿瘤表现出宫体侵犯。肿瘤体积中位数为33.5 mL(范围1 - 628)。平均随访时间为4.5年。85例患者复发,89例死亡(70例在失败后死亡,19例因其他原因死亡)。5年时,所有患者的无失败生存率为62%,局部无失败生存率为88%,淋巴结无失败生存率为69%,远处无失败生存率为74%。宫体侵犯、肿瘤体积和年龄均与局部、淋巴结和远处(肿瘤体积除外)部位的失败风险高度显著且独立相关。在存在这些因素的情况下,临床肿瘤直径和FIGO分期与任何类型失败的风险均无显著相关性。